ITMI20041628A1 - Sistema terapeutico a rilascio controllato per uso topico transdermico - Google Patents

Sistema terapeutico a rilascio controllato per uso topico transdermico

Info

Publication number
ITMI20041628A1
ITMI20041628A1 IT001628A ITMI20041628A ITMI20041628A1 IT MI20041628 A1 ITMI20041628 A1 IT MI20041628A1 IT 001628 A IT001628 A IT 001628A IT MI20041628 A ITMI20041628 A IT MI20041628A IT MI20041628 A1 ITMI20041628 A1 IT MI20041628A1
Authority
IT
Italy
Prior art keywords
controlled release
therapeutic system
topical transdermal
transdermal use
release
Prior art date
Application number
IT001628A
Other languages
English (en)
Inventor
Grigoli Maurizio Di
Pierbruno Romelli
Roberto Scarsetto
Paola Stefanelli
Original Assignee
Bouty S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bouty S P A filed Critical Bouty S P A
Priority to IT001628A priority Critical patent/ITMI20041628A1/it
Publication of ITMI20041628A1 publication Critical patent/ITMI20041628A1/it
Priority to US11/659,379 priority patent/US20080292708A1/en
Priority to CN2005800265976A priority patent/CN101001616B/zh
Priority to AU2005268981A priority patent/AU2005268981B2/en
Priority to AT05763405T priority patent/ATE550040T1/de
Priority to JP2007524204A priority patent/JP2008509096A/ja
Priority to ES05763405T priority patent/ES2387200T3/es
Priority to PT05763405T priority patent/PT1784169E/pt
Priority to CA002576087A priority patent/CA2576087A1/en
Priority to RU2007104354/04A priority patent/RU2401126C2/ru
Priority to PL05763405T priority patent/PL1784169T3/pl
Priority to MX2007001560A priority patent/MX2007001560A/es
Priority to EP05763405A priority patent/EP1784169B1/en
Priority to PCT/EP2005/007293 priority patent/WO2006012966A1/en
Priority to US14/085,334 priority patent/US20140080911A1/en
Priority to US15/414,829 priority patent/US10328034B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593—Polyesters, e.g. PLGA or polylactide-co-glycolide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT001628A 2004-08-06 2004-08-06 Sistema terapeutico a rilascio controllato per uso topico transdermico ITMI20041628A1 (it)

Priority Applications (16)

Application Number Priority Date Filing Date Title
IT001628A ITMI20041628A1 (it) 2004-08-06 2004-08-06 Sistema terapeutico a rilascio controllato per uso topico transdermico
PCT/EP2005/007293 WO2006012966A1 (en) 2004-08-06 2005-07-06 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
ES05763405T ES2387200T3 (es) 2004-08-06 2005-07-06 Matriz adhesiva polimercia con grupos carboxílicos salificados para uso transdérmico
CA002576087A CA2576087A1 (en) 2004-08-06 2005-07-06 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
AU2005268981A AU2005268981B2 (en) 2004-08-06 2005-07-06 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
AT05763405T ATE550040T1 (de) 2004-08-06 2005-07-06 Polymer-klebematrix mit salifizierten carboxylgruppen für die transdermale anwendung
JP2007524204A JP2008509096A (ja) 2004-08-06 2005-07-06 経皮用途のための塩化カルボキシル基を有するポリマー接着性マトリクス
US11/659,379 US20080292708A1 (en) 2004-08-06 2005-07-06 Polymeric Adhesive Matrix with Salified Carboxylic Groups for Transdermal Use
PT05763405T PT1784169E (pt) 2004-08-06 2005-07-06 Matriz polimérica adesiva com grupos carboxílicos salificados para uso transdérmico
CN2005800265976A CN101001616B (zh) 2004-08-06 2005-07-06 用于透皮应用的其中羧基成盐的聚合物粘性基质
RU2007104354/04A RU2401126C2 (ru) 2004-08-06 2005-07-06 Полимерная адгезивная матрица с карбоксильными группами, образующими соли, для трансдермального применения
PL05763405T PL1784169T3 (pl) 2004-08-06 2005-07-06 Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowania
MX2007001560A MX2007001560A (es) 2004-08-06 2005-07-06 Matriz adhesiva polimerica con grupos carboxilicos salificados para uso transdermico.
EP05763405A EP1784169B1 (en) 2004-08-06 2005-07-06 Polymeric adhesive matrix with salified carboxylic groups for transdermal use
US14/085,334 US20140080911A1 (en) 2004-08-06 2013-11-20 Polymeric Adhesive Matrix with Salified Carboxylic Groups for Transdermal Use
US15/414,829 US10328034B2 (en) 2004-08-06 2017-01-25 Polymeric adhesive matrix with salified carboxylic groups for transdermal use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001628A ITMI20041628A1 (it) 2004-08-06 2004-08-06 Sistema terapeutico a rilascio controllato per uso topico transdermico

Publications (1)

Publication Number Publication Date
ITMI20041628A1 true ITMI20041628A1 (it) 2004-11-06

Family

ID=35149597

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001628A ITMI20041628A1 (it) 2004-08-06 2004-08-06 Sistema terapeutico a rilascio controllato per uso topico transdermico

Country Status (14)

Country Link
US (3) US20080292708A1 (it)
EP (1) EP1784169B1 (it)
JP (1) JP2008509096A (it)
CN (1) CN101001616B (it)
AT (1) ATE550040T1 (it)
AU (1) AU2005268981B2 (it)
CA (1) CA2576087A1 (it)
ES (1) ES2387200T3 (it)
IT (1) ITMI20041628A1 (it)
MX (1) MX2007001560A (it)
PL (1) PL1784169T3 (it)
PT (1) PT1784169E (it)
RU (1) RU2401126C2 (it)
WO (1) WO2006012966A1 (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002250293B2 (en) 2001-03-09 2007-10-11 Arnason, Barry G. Mr Polymeric immunoglobulin fusion proteins that target low-affinity FCGammaReceptors
JP5820469B2 (ja) * 2010-04-30 2015-11-24 テイコク ファーマ ユーエスエー インコーポレーテッド プロピニルアミノインダンの経皮組成物
CN103476404B (zh) 2011-03-24 2017-09-29 帝国制药美国公司 包含活性剂层和活性剂转化层的透皮组合物
WO2013070526A1 (en) 2011-11-09 2013-05-16 Teikoku Pharma Usa, Inc. Methods for the treatment of skin neoplasms
DE102012000369A1 (de) 2012-01-11 2013-07-11 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Transdermales therapeutisches System mit Cholinesterase-Hemmer
AU2013338243B2 (en) 2012-11-02 2016-09-29 Teikoku Seiyaku Co., Ltd. Propynylaminoindan transdermal compositions
EA034204B1 (ru) 2014-10-17 2020-01-16 Фидия Фармачеутичи С.П.А. Дермальная терапевтическая система с высокой адгезивной способностью
PL3338768T3 (pl) 2016-12-20 2020-05-18 Lts Lohmann Therapie-Systeme Ag Transdermalny system terapeutyczny zawierający asenapinę
ES3001152T3 (es) 2016-12-20 2025-03-04 Lts Lohmann Therapie Systeme Ag Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno
WO2019002204A1 (en) 2017-06-26 2019-01-03 Lts Lohmann Therapie-Systeme Ag TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
EP3810099A1 (en) 2018-06-20 2021-04-28 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine
AU2019291060B2 (en) 2018-06-20 2024-09-05 Lts Lohmann Therapie-Systeme Ag Transdermal therapeutic system containing asenapine
KR102068595B1 (ko) * 2018-08-06 2020-01-21 고세윤 생체의료용 고분자를 포함하는 체온 감응형 점착제 조성물 및 이를 이용한 점착시트

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58103317A (ja) 1981-12-12 1983-06-20 Nitto Electric Ind Co Ltd ヒドロゾル製剤
CH643138A5 (de) * 1983-08-29 1984-05-30 Mepha Ag Indomethacin enthaltende, gelartige salbe.
JPS6229516A (ja) * 1985-07-30 1987-02-07 Nitto Electric Ind Co Ltd 医薬製剤
DE3901551A1 (de) * 1989-01-20 1990-07-26 Lohmann Therapie Syst Lts Superfizielles therapeutisches system mit einem gehalt an einem antineoplastischen wirkstoff, insbesondere 5-fluoruracil
DE3913734C2 (de) * 1989-04-26 1998-08-20 Roehm Gmbh Verwendung einer wäßrigen Hauthaftkleberlösung zur Herstellung einer mit Wasser leicht abwaschbaren Klebschicht
US5041287A (en) * 1989-05-22 1991-08-20 Terry L. Driggers Sprayable composition using acetone solvent
DE4238223C1 (de) * 1992-11-12 1994-05-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System zur Verabreichung von Physostigmin an die Haut und Verfahren zu dessen Herstellung
FR2709770B1 (fr) 1993-09-10 1995-10-13 Peller Entr Mur de soutènement ou anti-bruit.
FR2719770A1 (fr) * 1994-05-11 1995-11-17 Lhd Lab Hygiene Dietetique Système matriciel pour administration transdermique d'ibuprofène et procédé de préparation.
DE4429791C2 (de) * 1994-08-23 1997-04-24 Lohmann Therapie Syst Lts Medizinischer Haftkleber auf Basis von Polyacrylaten und dessen Verwendung
ATE288256T1 (de) * 1999-01-14 2005-02-15 Noven Pharma Dermale zusammensetzungen
DE19918106A1 (de) * 1999-04-22 2000-10-26 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit neutralisierten Acrylathaftklebern
US6562369B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of androgenic drugs hydroxide-releasing agents as permeation enhancers
US6645520B2 (en) * 1999-12-16 2003-11-11 Dermatrends, Inc. Transdermal administration of nonsteroidal anti-inflammatory drugs using hydroxide-releasing agents as permeation enhancers
DE10035891A1 (de) * 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
DE10110391A1 (de) 2001-03-03 2002-09-26 Lohmann Therapie Syst Lts Hochflexibles Nikotin transdermales therapeutisches System mit Nikotin als Wirkstoff
ITMI20020798A1 (it) * 2002-04-15 2003-10-15 F T Holding S A Cerotti transdermici a matrice adesiva siliconica stabilizzati con copolimeri metacrilici

Also Published As

Publication number Publication date
JP2008509096A (ja) 2008-03-27
EP1784169A1 (en) 2007-05-16
US20170128383A1 (en) 2017-05-11
AU2005268981B2 (en) 2010-05-13
RU2007104354A (ru) 2008-08-10
CN101001616A (zh) 2007-07-18
RU2401126C2 (ru) 2010-10-10
WO2006012966A1 (en) 2006-02-09
MX2007001560A (es) 2008-03-05
ATE550040T1 (de) 2012-04-15
AU2005268981A1 (en) 2006-02-09
US20140080911A1 (en) 2014-03-20
EP1784169B1 (en) 2012-03-21
AU2005268981A2 (en) 2006-02-09
CN101001616B (zh) 2010-06-16
CA2576087A1 (en) 2006-02-09
US10328034B2 (en) 2019-06-25
PL1784169T3 (pl) 2012-08-31
US20080292708A1 (en) 2008-11-27
PT1784169E (pt) 2012-06-26
ES2387200T3 (es) 2012-09-17

Similar Documents

Publication Publication Date Title
PL1784169T3 (pl) Polimerowa matryca adhezyjna z grupami karboksylowymi przekształconymi w sole do przezskórnego stosowania
NO20082988L (no) Vedvarende frigivningsformulering innbefattende oktreotid og to eller flere polylaktid-ko-glykolidpolymerer
EP2589379A4 (en) TRANSDERMAL AGGREGATE FREEZING SYSTEM WITH DONEPEZIL
ATE455541T1 (de) Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl
DK2029121T3 (da) Transdermalt terapeutisk system indeholdende partikler af virksom bestanddel og med forøget strøm af virksom bestanddel
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
EA200700049A1 (ru) Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением
PA8491001A1 (es) Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc.
AR072492A1 (es) Dispositivo y administracion transdermica de estrogeno
ES2167116T3 (es) Sistema terapeutico transdermico (tts) que contiene pergolida.
DE60233944D1 (de) Wirkstoffabgabesysteme
CY1111977T1 (el) Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
HRP20191795T1 (hr) Medicinska upotreba spojeva artemizinina i agonista gefirina
ITMI20020514A0 (it) Sistema terapeutico per il rilascio controllato di uno o piu' principi attivi
CY1114311T1 (el) Θεραπευτικα συστηματα αμεσης απελευθερωσης για βελτιωμενη απο του στοματος απορροφηση 7-[(ε)-τριτ-βουτυλοξυιμινομεθυλο]καμπτοθεκινης
CY1113759T1 (el) Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2
BR112022012255A2 (pt) Formulações injetáveis de ação prolongada de sais de pamoato de cetamina
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
NO20073457L (no) Stabile sammensetninger av fenofibrat med fettsyreestere
ATE347358T1 (de) Schwimmende orale formulierungen mit kontrollierter freisetzung von betain
DK1143938T3 (da) Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type
ES2195538T3 (es) Composicion farmaceutica que comprende una combinacion de isomeros dextro y levo de sotalol.
AR048342A1 (es) FORMAS DE DOSIFICACIoN FARMACÉUTICAS QUE COMPRENDEN EL ÁCIDO N-(2-(2-FTALIMIDOETOXI)-ACETIL)-L-ALANIL-D-GLUTÁMICO (LK-423)
AR028525A1 (es) Sistema terapeutico transdermal para la administracion de lerisetron
DE60321572D1 (de) Transdermales arzneimittelverabreichungssystem